APA citiranje

Tsumura, H., Satoh, T., Ishiyama, H., Tabata, K., Komori, S., Sekiguchi, A., . . . Iwamura, M. (2016). Prostate-specific antigen nadir after high-dose-rate brachytherapy predicts long-term survival outcomes in high-risk prostate cancer. J Contemp Brachytherapy.

Citação norma Chicago

Tsumura, Hideyasu, et al. "Prostate-specific Antigen Nadir After High-dose-rate Brachytherapy Predicts Long-term Survival Outcomes in High-risk Prostate Cancer." J Contemp Brachytherapy 2016.

MLA citiranje

Tsumura, Hideyasu, et al. "Prostate-specific Antigen Nadir After High-dose-rate Brachytherapy Predicts Long-term Survival Outcomes in High-risk Prostate Cancer." J Contemp Brachytherapy 2016.